Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 fatty acids in bariatric gastric bypass surgery
2013-004750-24Phase 4Active
- Sponsor
- Rode Kruis Ziekenhuis
- Start
- Jan 2014
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of omega-3-acid triglycerides in class III obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) (2 arms), sponsored by Rode Kruis Ziekenhuis. Primary endpoint: Volume of the left hepatic lobe. Started Jan 2014; status: active.
02
Drugs
omega-3-acid triglycerides
03
Conditions
class III obesitymetabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on 2013-004750-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004750-24.